Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin

Chronic hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. In the last 5 years, treatment for HCV infection has experienced a marked development. In 2014, the use of ledipasvir/sofosbuvir with or without concomitant weight-based ribavirin was approved wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballester-Ferré, Maria Pilar, Martínez, Fernando, Garcia-Gimeno, Natalia, Mora, Francisco, Serra, Miguel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295150/
https://www.ncbi.nlm.nih.gov/pubmed/28217253
http://dx.doi.org/10.4254/wjh.v9.i3.161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295150/
https://www.ncbi.nlm.nih.gov/pubmed/28217253
http://dx.doi.org/10.4254/wjh.v9.i3.161

Ejemplares similares